ASX:CYP

Why Cynata Therapeutics’ Share Price Crashed 31.07% Today

Australian stem cell research company Cynata Therapeutics' share price tumbled 31.64% this morning, shedding 55 cents to trade at $1.22. This morning’s nosedive comes on the back of strong gains made since the beginning of December, climbing 84.5% to reach $1.79 — its highest price since October 2010.
Money Morning Australia